
BGLC Market Capitalization Overview
Market Cap: $4.97M as of Jun 13, 2025
$4.97M
Past Month-$499.60K (9.15%)
As of Jun 13, 2025, BGLC has a market capitalization of $4.97M. Over the past 30 days, its market cap has increased by 32.72%, while in the last 12 months, it has increased by 1,084.96%.
Market capitalization represents the total value of BioNexus Gene Lab Corp as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
BGLC Market Cap Formula = Stock Price * Shares Outstanding
The market cap of BGLC helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of BioNexus Gene Lab Corp as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
BGLC Market Cap Formula = Stock Price * Shares Outstanding
The market cap of BGLC helps investors assess the company's size and compare it with competitors for better investment decisions.
BGLC Market Cap & Key Trends
See BioNexus Gene Lab Corp’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in BGLC
Order type
Buy in
Order amount
Est. shares
0 shares
BGLC Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $6.65M | +32.72% |
May 1, 2025 | $5.01M | +1,186.54% |
Apr 1, 2025 | $389.30K | -20.66% |
Mar 3, 2025 | $490.70K | -18.47% |
Feb 3, 2025 | $601.90K | +0.75% |
Jan 2, 2025 | $597.40K | +13.99% |
BGLC End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $4.97M | +1,084.96% |
2024 | $418.80K | -46.70% |
2023 | $785.80K | -94.29% |
2022 | $13.76M | -54.75% |
2021 | $30.40M | -7.39% |
2020 | $32.82M | — |
FAQs About BioNexus Gene Lab Corp (BGLC) Market Cap
As of Jun 13, 2025, the market capitalization of BGLC is $4.97M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, BioNexus Gene Lab Corp’s market capitalization has decreased by -9.15%, changing from $5.47M to $4.97M as of Jun 13, 2025.
In the last 3 months, BioNexus Gene Lab Corp’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, BioNexus Gene Lab Corp’s market capitalization decreased from $785.80K in January to $418.80K in December, reflecting a -46.7% change.
In the past five years, BGLC has had a compound annual growth rate (CAGR) of -58.20% in market capitalization. This means its market cap has shrunk at an average rate of -58.20% per year.